Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 reverse transcriptase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Trypanosoma congolense | RNA helicase, putative | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Trypanosoma brucei | RNA helicase, putative | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Schistosoma mansoni | hypothetical protein | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Plasmodium yoelii | integrase-related | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | dynein-related AAA-type ATPase, putative | 0.0145 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0145 | 0 | 0.5 |
Plasmodium vivax | circumsporozoite- and TRAP-related protein, putative | 0.0145 | 0 | 0.5 |
Brugia malayi | Cache domain containing protein | 0.1573 | 0.1862 | 1 |
Treponema pallidum | hypothetical protein | 0.0145 | 0 | 0.5 |
Entamoeba histolytica | elongation factor-2 kinase, putative | 0.0145 | 0 | 0.5 |
Plasmodium falciparum | thrombospondin-related anonymous protein | 0.0145 | 0 | 0.5 |
Onchocerca volvulus | 0.0145 | 0 | 0.5 | |
Toxoplasma gondii | microneme protein MIC2 | 0.0145 | 0 | 0.5 |
Plasmodium vivax | von Willebrand factor A domain-related protein, putative | 0.0145 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0145 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1573 | 0.1862 | 1 |
Onchocerca volvulus | 0.0145 | 0 | 0.5 | |
Onchocerca volvulus | 0.0145 | 0 | 0.5 | |
Onchocerca volvulus | 0.0145 | 0 | 0.5 | |
Onchocerca volvulus | 0.0145 | 0 | 0.5 | |
Entamoeba histolytica | hypothetical protein, conserved | 0.0145 | 0 | 0.5 |
Onchocerca volvulus | 0.0145 | 0 | 0.5 | |
Echinococcus granulosus | voltage dependent calcium channel subunit | 0.3553 | 0.4445 | 0.4445 |
Plasmodium vivax | thrombospondin-related anonymous protein | 0.0145 | 0 | 0.5 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.1718 | 0.2052 | 0.4821 |
Plasmodium vivax | hypothetical protein, conserved | 0.0145 | 0 | 0.5 |
Toxoplasma gondii | von Willebrand factor type A domain-containing protein | 0.0145 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.1835 | 0.2204 | 0.5179 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.3553 | 0.4445 | 0.4445 |
Plasmodium falciparum | circumsporozoite- and TRAP-related protein | 0.0145 | 0 | 0.5 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.3408 | 0.4256 | 1 |
Schistosoma mansoni | serine-rich repeat protein | 0.1835 | 0.2204 | 0.5179 |
Onchocerca volvulus | 0.0145 | 0 | 0.5 | |
Treponema pallidum | 76K protein | 0.0145 | 0 | 0.5 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.7812 | 1 | 1 |
Plasmodium falciparum | von Willebrand factor A domain-related protein | 0.0145 | 0 | 0.5 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0145 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.